Gottlieb to Delayers of Generics: ‘End the Shenanigans’

Drug Industry Daily
A A
FDA Commissioner Scott Gottlieb once again chastised brand-name companies that slow-walk federal procedures and use regulations to delay the entry of generic competitors.

To View This Article:

Login

Subscribe To Drug Industry Daily